WilmerHale Advises Medtronic in $3.5 Billion Financing

WilmerHale Advises Medtronic in $3.5 Billion Financing

Firm News

Related Solutions

We guide clients through today’s ever-changing debt markets, representing them in a broad variety of debt deals that range from complex financial structures to traditional loan transactions.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
Critical industry insight and formidable strength across key practices.

WilmerHale represented Medtronic plc and its wholly-owned subsidiaries, Medtronic, Inc. and Medtronic Global Holdings S.C.A., in the closing of an amended and restated $3.5 billion syndicated revolving credit facility with Bank of America as administrative agent, and Merrill Lynch, Citibank, Deutsche Bank, JPMorgan, Barclays, Goldman Sachs, HSBC Bank and Mizuho Bank as joint lead arrangers, on December 12, 2018. The multi-jurisdiction and multi-currency facility, which backstops Medtronic’s $3.5 billion commercial paper program, has a five-year maturity with two one-year extension options. 

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies—alleviating pain, restoring health and extending life for millions of people around the world.  

The multi-disciplinary WilmerHale team on this transaction consisted of Justin Ochs, Erika Robinson, Julie Hogan Rodgers, Tim Silva, Mona Shin, Meghan Walsh, Seth Davis and Elizabeth Brasher.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel